D110N (p.Asp110Asn) variant of DRD3 (Dopamine receptor D3)
D110N (p.Asp110Asn) in DRD3 (Dopamine receptor D3) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 1.00 / 1. The record also includes structural context.
D110N (p.Asp110Asn) variant details
- p.Asp110Asn
- NCI-TCGA Cosmic COSV5568
- cosmic curated COSV55682
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.996
- ESM-1b 1.00
- AlphaMissense 0.99
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available